Harbin Pharmaceutical Group Co Ltd
SSE:600664

Watchlist Manager
Harbin Pharmaceutical Group Co Ltd Logo
Harbin Pharmaceutical Group Co Ltd
SSE:600664
Watchlist
Price: 3.5 CNY -0.57% Market Closed
Market Cap: 8.8B CNY

Profitability Summary

Harbin Pharmaceutical Group Co Ltd's profitability score is 48/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

48/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

48/100
Profitability
Score
48/100
Profitability
Score

Margins

Earnings Waterfall
Harbin Pharmaceutical Group Co Ltd

Margins Comparison
Harbin Pharmaceutical Group Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Harbin Pharmaceutical Group Co Ltd
SSE:600664
8.8B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
277.8B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
217.9B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.8B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
213.9B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Harbin Pharmaceutical Group Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Harbin Pharmaceutical Group Co Ltd
SSE:600664
8.8B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
277.8B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
217.9B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.8B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
213.9B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Harbin Pharmaceutical Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate